Your browser doesn't support javascript.
loading
Transcriptional profiles define drug refractory disease in myeloma.
Zhu, Yuan Xiao; Bruins, Laura A; Chen, Xianfeng; Shi, Chang-Xin; Bonolo De Campos, Cecilia; Meurice, Nathalie; Wang, Xuewei; Ahmann, Greg J; Ramsower, Colleen A; Braggio, Esteban; Rimsza, Lisa M; Stewart, A Keith.
Afiliação
  • Zhu YX; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Bruins LA; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Chen X; Division of Biomedical Statistics and Informatics, Department of Health Science Research Mayo Clinic Rochester Minnesota USA.
  • Shi CX; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Bonolo De Campos C; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Meurice N; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Wang X; Division of Biomedical Statistics and Informatics, Department of Health Science Research Mayo Clinic Rochester Minnesota USA.
  • Ahmann GJ; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Ramsower CA; Department of Laboratory Medicine and Pathology Mayo Clinic Phoenix Arizona USA.
  • Braggio E; Division of Hematology-Oncology Mayo Clinic Phoenix Arizona USA.
  • Rimsza LM; Department of Laboratory Medicine and Pathology Mayo Clinic Phoenix Arizona USA.
  • Stewart AK; Division of Medical Oncology and Hematology Princess Margaret Cancer Centre Toronto Ontario Canada.
EJHaem ; 3(3): 804-814, 2022 Aug.
Article em En | MEDLINE | ID: mdl-36051067

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: EJHaem Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: EJHaem Ano de publicação: 2022 Tipo de documento: Article